MTARC1 and metabolic dysfunction-associated steatotic liver disease: In conclusion, we demonstrate that MTARC1 p.A165T, and to a lesser extent, HSD17B13 rs72613567 polymorphism can be protective against NAFLD-related liver injury in patients with obesity scheduled for bariatric surgery.